Eads & Heald Wealth Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,755
Closed -$184K 141
2024
Q4
$184K Hold
14,755
0.09% 135
2024
Q3
$171K Buy
14,755
+85
+0.6% +$981 0.08% 142
2024
Q2
$156K Buy
14,670
+2,600
+22% +$28.7K 0.08% 143
2024
Q1
$144K Buy
12,070
+193
+2% +$2.33K 0.07% 143
2023
Q4
$129K Sell
11,877
-7,895
-40% -$75.6K 0.06% 145
2023
Q3
$195K Sell
19,772
-63
-0.3% -$656 0.1% 141
2023
Q2
$198K Buy
19,835
+820
+4% +$7.83K 0.1% 144
2023
Q1
$183K Buy
19,015
+4,435
+30% +$49.2K 0.09% 144
2022
Q4
$162K Buy
14,580
+225
+2% +$2.35K 0.08% 145
2022
Q3
$122K Buy
+14,355
New +$141K 0.07% 142

Other funds holding VTRS

Eads & Heald Wealth Management's VTRS Position: Q1 2025 in Review

Eads & Heald Wealth Management sold out of Viatris (VTRS) in Q1 2025, closing a stake of 14,755 shares — an estimated $184K sold.

Eads & Heald Wealth Management first reported a position in VTRS in Q3 2022 and held it in 10 quarters. The position peaked at $198K in Q2 2023. 1,008 funds tracked by Wall St. Rank hold VTRS as of Q1 2025.

  • Eads & Heald Wealth Management reported no remaining Viatris position as of Q1 2025 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 14,755 Viatris shares in Q1 2025, an estimated $184K.
  • Eads & Heald Wealth Management first reported a position in Viatris in Q3 2022 and held it in 10 quarters.
  • Eads & Heald Wealth Management's Viatris position peaked at $198K in Q2 2023.
  • 1,008 funds tracked by Wall St. Rank held Viatris as of Q1 2025.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2025, filed 25 Apr 2025.